Literature DB >> 29472642

Role of trace amine-associated receptor 1 in nicotine's behavioral and neurochemical effects.

Jian-Feng Liu1,2, Robert Seaman1, Justin N Siemian1, Rohan Bhimani3, Bernard Johnson1, Yanan Zhang4, Qing Zhu1,2, Marius C Hoener5, Jinwoo Park3, David M Dietz1, Jun-Xu Li6.   

Abstract

Nicotine addiction and abuse remains a global health issue. To date, the fundamental neurobiological mechanism of nicotine addiction remains incompletely understood. Trace amine-associated receptor 1 (TAAR1) is thought to directly modulate dopaminergic system and are thought to be a neural substrate underlying addictive-like behaviors. We aimed to investigate the role of TAAR1 in nicotine addictive-like behaviors. TAAR1 expression after nicotine treatment was evaluated by western blotting. c-Fos immunofluorescence and in vivo fast-scan cyclic voltammetry were used to examine the activation of brain regions and dopamine release, respectively. We then thoroughly and systematically examined the role of TAAR1 in mediating nicotine-induced sensitization, nicotine discrimination, nicotine self-administration, nicotine demand curve, and the reinstatement of nicotine-seeking. Local pharmacological manipulation was conducted to determine the role of TAAR1 in the nucleus accumbens (NAcs) in the reinstatement of nicotine-seeking. We found that the expression of TAAR1 protein was selectively downregulated in the NAc, with no change in either dorsal striatum or prefrontal cortex. TAAR1 activation was sufficient to block nicotine-induced c-Fos expression in the NAc, while also reducing nicotine-induced dopamine release in the NAc. Systemic administration of TAAR1 agonists attenuated the expression and development of nicotine-induced sensitization, nicotine self-administration, the reinstatement of nicotine-seeking, and increased the elasticity of nicotine demand curve, while intra-NAc infusions of a TAAR1 agonist was sufficient to attenuate nicotine reinstatement. Moreover, TAAR1-knockout rats showed augmented cue-induced and drug-induced reinstatement of nicotine-seeking. These results indicated that modulation of TAAR1 activity regulates nicotine addictive-like behaviors and TAAR1 represents a novel target towards the treatment of nicotine addiction.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29472642      PMCID: PMC6180004          DOI: 10.1038/s41386-018-0017-9

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  49 in total

Review 1.  Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy.

Authors:  N R Richardson; D C Roberts
Journal:  J Neurosci Methods       Date:  1996-05       Impact factor: 2.390

2.  Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.

Authors:  D Leo; L Mus; S Espinoza; M C Hoener; T D Sotnikova; R R Gainetdinov
Journal:  Neuropharmacology       Date:  2014-02-22       Impact factor: 5.250

Review 3.  Relationship between the discriminative stimulus properties and subjective effects of drugs.

Authors:  C R Schuster; C E Johanson
Journal:  Psychopharmacol Ser       Date:  1988

Review 4.  Tribute to: Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area [William Corrigall, Kathleen Coen and Laurel Adamson, Brain Res. 653 (1994) 278-284].

Authors:  Francesco Leri; Franco J Vaccarino
Journal:  Brain Res       Date:  2016-02-08       Impact factor: 3.252

5.  Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro.

Authors:  Zhihua Xie; Susan V Westmoreland; Mary E Bahn; Guo-Lin Chen; Hong Yang; Eric J Vallender; Wei-Dong Yao; Bertha K Madras; Gregory M Miller
Journal:  J Pharmacol Exp Ther       Date:  2007-01-18       Impact factor: 4.030

6.  Role of hippocampal β-adrenergic and glucocorticoid receptors in the novelty-induced enhancement of fear extinction.

Authors:  Jian-Feng Liu; Chang Yang; Jia-Hui Deng; Wei Yan; Hui-Min Wang; Yi-Xiao Luo; Hai-Shui Shi; Shi-Qiu Meng; Bai-Sheng Chai; Qin Fang; Ning Chai; Yan-Xue Xue; Jia Sun; Chen Chen; Xue-Yi Wang; Ji-Shi Wang; Lin Lu
Journal:  J Neurosci       Date:  2015-05-27       Impact factor: 6.167

7.  Simultaneous amperometric measurement of ascorbate and catecholamine secretion from individual bovine adrenal medullary cells.

Authors:  P S Cahill; R M Wightman
Journal:  Anal Chem       Date:  1995-08-01       Impact factor: 6.986

8.  Antinociceptive effects of imidazoline I2 receptor agonists in the formalin test in rats.

Authors:  David A Thorn; Yanyan Qiu; Shushan Jia; Yanan Zhang; Jun-Xu Li
Journal:  Behav Pharmacol       Date:  2016-06       Impact factor: 2.293

Review 9.  Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis.

Authors:  Michael D Scofield; Peter W Kalivas
Journal:  Neuroscientist       Date:  2014-02-03       Impact factor: 7.519

10.  The trace amine-associated receptor 1 modulates methamphetamine's neurochemical and behavioral effects.

Authors:  Rachel Cotter; Yue Pei; Liudmila Mus; Anja Harmeier; Raul R Gainetdinov; Marius C Hoener; Juan J Canales
Journal:  Front Neurosci       Date:  2015-02-13       Impact factor: 4.677

View more
  16 in total

1.  The Claustrum-Prefrontal Cortex Pathway Regulates Impulsive-Like Behavior.

Authors:  Jianfeng Liu; Ruyan Wu; Bernard Johnson; Jimmy Vu; Caroline Bass; Jun-Xu Li
Journal:  J Neurosci       Date:  2019-11-08       Impact factor: 6.167

Review 2.  TAAR Agonists.

Authors:  Zhengrong Xu; Qian Li
Journal:  Cell Mol Neurobiol       Date:  2019-12-17       Impact factor: 5.046

Review 3.  TAAR1 and Psychostimulant Addiction.

Authors:  Jianfeng Liu; Ruyan Wu; Jun-Xu Li
Journal:  Cell Mol Neurobiol       Date:  2020-01-23       Impact factor: 5.046

4.  Effects of a trace amine-associated receptor 1 agonist RO 5263397 on ethanol-induced behavioral sensitization.

Authors:  Ruyan Wu; Jianfeng Liu; Kaixuan Wang; Yufei Huang; Yanan Zhang; Jun-Xu Li
Journal:  Behav Brain Res       Date:  2020-05-12       Impact factor: 3.332

Review 5.  Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders.

Authors:  Ruyan Wu; Jun-Xu Li
Journal:  CNS Drugs       Date:  2021-11-12       Impact factor: 5.749

6.  TAAR1 agonists attenuate extended-access cocaine self-administration and yohimbine-induced reinstatement of cocaine-seeking.

Authors:  Jianfeng Liu; Bernard Johnson; Ruyan Wu; Robert Seaman; Jimmy Vu; Qing Zhu; Yanan Zhang; Jun-Xu Li
Journal:  Br J Pharmacol       Date:  2020-05-05       Impact factor: 8.739

Review 7.  Drug addiction: a curable mental disorder?

Authors:  Jian-Feng Liu; Jun-Xu Li
Journal:  Acta Pharmacol Sin       Date:  2018-10-31       Impact factor: 6.150

8.  Interleukin-1 receptor-associated kinase 4 (IRAK4) in the nucleus accumbens regulates opioid-seeking behavior in male rats.

Authors:  Ruyan Wu; Jianfeng Liu; Jimmy Vu; Yufei Huang; David M Dietz; Jun-Xu Li
Journal:  Brain Behav Immun       Date:  2021-12-24       Impact factor: 7.217

9.  Activation of trace amine-associated receptor 1 selectively attenuates the reinforcing effects of morphine.

Authors:  Jianfeng Liu; Robert Seaman; Bernard Johnson; Ruyan Wu; Jimmy Vu; Jingwei Tian; Yanan Zhang; Jun-Xu Li
Journal:  Br J Pharmacol       Date:  2021-01-04       Impact factor: 8.739

10.  Activation of trace amine-associated receptor 1 attenuates nicotine withdrawal-related effects.

Authors:  Ruyan Wu; Jianfeng Liu; Bernard Johnson; Yufei Huang; Yanan Zhang; Jun-Xu Li
Journal:  Addict Biol       Date:  2021-06-25       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.